Article Text

Download PDFPDF
Co-dydramol – specify the strength

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has stressed the importance of specifying the strength of co-dydramol products when they are generically prescribed to minimise dispensing errors and the risk of accidental opioid overdose.1 The MHRA notes that the ratio of dihydrocodeine to paracetamol in co-dydramol was previously fixed at 1:50 (dihydrocodeine 10mg and paracetamol …

View Full Text